A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor ...
Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, ...
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of ...
Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...
An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...
The experimental treatment, developed using cells at La Paz public hospital, achieves a preliminary survival rate of 70% in ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...
A groundbreaking study at Vanderbilt University Medical Center (VUMC) is changing the face of kidney cancer treatment.Doctors ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Global Cancer Antibody Drug Conjugates Market Opportunity USD 70 Billion Opportunty By 2031 ...
An orchiectomy is a surgery that removes a testicle. Testes-sparing surgery is when a doctor removes the tumor and leaves the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback